Top Markets
Coin of the day
Anxo Pharmaceutical Co., Ltd. Anxo Pharmaceutical Co., Ltd.

Anxo Pharmaceutical Co., Ltd.

6677
株式のランク #27945
Anxo Pharmaceutical Co., Ltd. functions as a specialized enterprise in the... Anxo Pharmaceutical Co., Ltd. functions as a specialized enterprise in the pharmaceutical sector. This company is actively involved in the research, production, and global distribution of various medicinal products, catering to both healthcare professionals and individual patients, particularly within Taiwan and across international markets. Its comprehensive product catalog features both prescription-only drugs and over-the-counter remedies, addressing a broad spectrum of therapeutic needs. These include cardiovascular health, metabolic disorders, conditions affecting the central nervous system, diabetes management, respiratory ailments, anti-infective treatments, dermatological issues, nephrology, urology, and orthopedics, among others. More specifically, Anxo supplies agents for antidiabetic and dyslipidemic conditions, supports cardiovascular and circulatory systems, offers therapies for the nervous system, addresses hepatological and gastroenterological concerns, provides anti-infective and antiviral agents, and assists with hemodialysis and urinary system treatments. Additionally, their offerings cover respiratory system and antihistamine applications, various analgesics, and other specialized medications, including a range of injectable pharmaceuticals. Established in 2003, the company's main operational base is situated in Taipei, Taiwan.
株価
$0.52786386
時価総額
$29.55M
変化(1日)
0.00%
変化(1年)
-23.48%
TW
取引 Anxo Pharmaceutical Co., Ltd. (6677)

カテゴリー

Anxo Pharmaceutical Co., Ltd.(6677)の利益
2026 時点の利益 TTM: 0
Anxo Pharmaceutical Co., Ltd. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Anxo Pharmaceutical Co., Ltd. の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。